GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,460 | 4,652 | 6,344 | -20,516 | -23,489 |
| Depreciation Amortization | 2,496 | 1,733 | 1,044 | 400 | 2,781 |
| Other Working Capital | 905 | 1,048 | 295 | 19 | -221 |
| Other Operating Activity | 13,402 | -11,146 | -10,763 | 18,310 | 19,180 |
| Operating Cash Flow | $-4,657 | $-3,713 | $-3,080 | $-1,787 | $-1,749 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | N/A | N/A | -6 |
| Investing Cash Flow | $-1 | $N/A | $N/A | $N/A | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,850 | 2,900 | 2,350 | 2,350 | 2,589 |
| Debt Repayment | N/A | N/A | N/A | N/A | -6 |
| Financing Cash Flow | $3,850 | $2,900 | $2,350 | $2,350 | $2,583 |
| Beginning Cash Position | 855 | 855 | 855 | 855 | 43 |
| End Cash Position | 47 | 42 | 125 | 1,418 | 855 |
| Net Cash Flow | $-808 | $-813 | $-730 | $563 | $812 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,657 | -3,713 | -3,080 | -1,787 | -1,749 |
| Capital Expenditure | -1 | N/A | N/A | N/A | -6 |
| Free Cash Flow | -4,658 | -3,713 | -3,080 | -1,787 | -1,755 |